Supporting Advanced Biotherapeutic Development

May 26, 2022 PAO-05-22-R250-10

In another interview from Pharma's Almanac's Road to 50 States trans-American road trip, Kevin Van Cott, Senior Director of HRMS at Prolytix (previously Haematologic Technologies) talks to Nigel about the high-resolution mass specrometry lab that Prolytix has started in Lincoln, Nebraska.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Protylix

Prolytix combines scientific excellence in protein chemistry and therapeutics with a personalized and consultative approach. With over 30 years of experience, our staff has the expertise needed to identify and solve your most complex large molecule drug development challenges. Our focus on partnership means you have direct access to our scientific team throughout the course of your project, ensuring you receive accurate results faster.

We provide holistic solutions for plasma-based protein therapies, monoclonal and polyclonal antibodies, cell and gene therapies, recombinant proteins, and vaccines and viral vectors.

Q: